Is ethinyl estradiol / levonorgestrel covered by Medicare Part D?
4,913 of 5,052 Medicare Part D plan offerings (97.2%) list ethinyl estradiol / levonorgestrel on their 2026 formulary, most often on tier 2; 0% of the formularies that cover it require prior authorization.
- Plans that cover it
- 97.2%
- 4,913 of 5,052 offerings; the median drug: 76%
- Usual tier
- Tier 2
- from tier 1 to tier 4
- Prior authorization
- 0%
- of formularies that cover it; the median drug: 1%
- Quantity limits
- 34.6%
- of formularies that cover it; the median drug: 30%
Source: CMS Part D formulary file, 2026 second quarter: the formularies in use in 2026. A plan's 2027 formulary can differ; check your own plan's coverage in Medicare Plan Finder.
What does it cost under Part D in 2027?
- Your yearly cap in 2027
- Out-of-pocket spending on covered Part D drugs stops at $2,400 in 2027 ($2,100 in 2026); after that, you pay nothing for covered drugs for the rest of the year.
- The deductible
- A plan's drug deductible is at most $700 in 2027 ($615 in 2026); many plans charge less or none.
Source: CMS, Announcement of calendar year 2027 Part D parameters; Medicare.gov, “How much does Medicare drug coverage cost?” (read Oct. 7, 2026).
Which forms and strengths are counted?
- pack of 21 × ethinyl estradiol 0.02 mg / levonorgestrel 0.1 mg oral tablet and 7 × inert ingredients 1 mg oral tablet
- pack of 21 × ethinyl estradiol 0.03 mg / levonorgestrel 0.15 mg oral tablet and 7 × inert ingredients 1 mg oral tablet
- pack of 28 × ethinyl estradiol 0.02 mg / levonorgestrel 0.09 mg oral tablet
- pack of 6 × ethinyl estradiol 0.03 mg / levonorgestrel 0.05 mg oral tablet and 10 × ethinyl estradiol 0.03 mg / levonorgestrel 0.125 mg oral tablet and 5 × ethinyl estradiol 0.04 mg / levonorgestrel 0.075 mg oral tablet and 7 × inert ingredients 1 mg oral tablet
- pack of 84 × ethinyl estradiol 0.03 mg / levonorgestrel 0.15 mg oral tablet and 7 × inert ingredients 1 mg oral tablet
Which other versions are listed?
The same ingredients under other names, each with its own coverage and spending.
- Aviane 28 (ethinyl estradiol / levonorgestrel)98.2% of plan offerings
- Portia (ethinyl estradiol / levonorgestrel)97.5% of plan offerings
- Marlissa (ethinyl estradiol / levonorgestrel)96.1% of plan offerings
- Kurvelo (ethinyl estradiol / levonorgestrel)95.8% of plan offerings
- Altavera (ethinyl estradiol / levonorgestrel)95.7% of plan offerings
- Levonest (ethinyl estradiol / levonorgestrel)95% of plan offerings
- Vienva (ethinyl estradiol / levonorgestrel)94.6% of plan offerings
- Lessina (ethinyl estradiol / levonorgestrel)94.2% of plan offerings
- Falmina (ethinyl estradiol / levonorgestrel)93.5% of plan offerings
- Setlakin (ethinyl estradiol / levonorgestrel)93.1% of plan offerings
- Aubra (ethinyl estradiol / levonorgestrel)92.9% of plan offerings
- Introvale (ethinyl estradiol / levonorgestrel)92.5% of plan offerings
- Iclevia (ethinyl estradiol / levonorgestrel)89.9% of plan offerings
- Lutera (ethinyl estradiol / levonorgestrel)87.2% of plan offerings
- Dolishale (ethinyl estradiol / levonorgestrel)69.9% of plan offerings
- Minzoya (ethinyl estradiol / levonorgestrel)5.7% of plan offerings
- Joyeaux (ethinyl estradiol / levonorgestrel)5.2% of plan offerings
- Balcoltra (ethinyl estradiol / levonorgestrel)under 0.1% of plan offerings
What else should you check?
- Stand-alone drug plans for 2027Premiums and deductibles
- Drugs Medicare spends the most onThe 2024 spending list
- 2027 costs and limitsDeductibles and out-of-pocket limits
Data, not medical advice. Coverage is the share of plan formularies listing the drug; your plan's formulary, tier and pharmacy decide what you pay.